{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:26:03Z","timestamp":1774679163967,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.exppara.2018.04.015","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T02:36:33Z","timestamp":1524796593000},"page":"66-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection"],"prefix":"10.1016","volume":"189","author":[{"given":"Hakim","family":"Azizi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadi","family":"Mirzaeei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Akbar","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Bazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliyar","family":"Mirzapour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kareem Hatam","family":"Nahavandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ako","family":"Azimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajar","family":"Yaghoobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.exppara.2018.04.015_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/jir.2009.0008","article-title":"Opioid-like activity of naltrexone on natural killer cell cytolytic activity and cytokine production in splenocytes: effects of alcohol","volume":"30","author":"Boyadjieva","year":"2010","journal-title":"J.\u00a0Interferon Cytokine Res."},{"issue":"10","key":"10.1016\/j.exppara.2018.04.015_bib2","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1007\/s00436-013-3553-6","article-title":"Immunization with recombinant leucine aminopeptidase showed protection against Fasciola gigantica in mice","volume":"112","author":"Changklungmoa","year":"2013","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2018.04.015_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.vetpar.2016.07.009","article-title":"Vaccine potential of recombinant cathepsinL1G against Fasciola gigantica in mice","volume":"226","author":"Changklungmoa","year":"2016","journal-title":"Vet. Parasitol."},{"issue":"1","key":"10.1016\/j.exppara.2018.04.015_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.exppara.2013.06.010","article-title":"Vaccine potential of recombinant cathepsin B against Fasciola gigantica","volume":"135","author":"Chantree","year":"2013","journal-title":"Exp. Parasitol."},{"issue":"3\u20134","key":"10.1016\/j.exppara.2018.04.015_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.vetpar.2013.04.008","article-title":"Immunomodulatory molecules of Fasciola hepatica: candidates for both vaccine and immunotherapeutic development","volume":"195","author":"Dalton","year":"2013","journal-title":"Vet. Parasitol."},{"issue":"8","key":"10.1016\/j.exppara.2018.04.015_bib6","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/eji.200838648","article-title":"Alum adjuvanticity: unraveling a century old mystery","volume":"38","author":"De Gregorio","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.exppara.2018.04.015_bib7","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1128\/IAI.02541-14","article-title":"Fasciola hepatica fatty acid binding protein induces the alternative activation of human macrophages","volume":"82","author":"Figueroa-Santiago","year":"2014","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.exppara.2018.04.015_bib8","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.vaccine.2009.12.084","article-title":"Convened by EUROPRISE WG. Vaccine adjuvants: a priority for vaccine research","volume":"28","author":"Harandi","year":"2010","journal-title":"Vaccine"},{"issue":"5\u20136","key":"10.1016\/j.exppara.2018.04.015_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.micpath.2007.06.001","article-title":"Naloxone, an opioid receptor antagonist, enhances induction of protective immunity against HSV-1 infection in BALB\/c mice","volume":"43","author":"Jamali","year":"2007","journal-title":"Microb. Pathog."},{"issue":"3","key":"10.1016\/j.exppara.2018.04.015_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/intimm\/dxn139","article-title":"A\u00a0novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine","volume":"21","author":"Jamali","year":"2009","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.exppara.2018.04.015_bib11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.micinf.2010.02.001","article-title":"Evaluation of the adjuvant activity of naloxone, an opioid receptor antagonist, in combination with heat-killed Listeria monocytogenes vaccine","volume":"12","author":"Jazani","year":"2010","journal-title":"Microb. Infect."},{"issue":"6","key":"10.1016\/j.exppara.2018.04.015_bib12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.imbio.2010.10.005","article-title":"Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Salmonella typhimurium infection","volume":"216","author":"Jazani","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.exppara.2018.04.015_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.exppara.2016.01.001","article-title":"Mixture of Alum - naloxone and Alum - naltrexone as a novel adjuvant elicits immune responses for Toxoplasma gondii lysate antigen in BALB\/c mice","volume":"162","author":"Khorshidvand","year":"2016","journal-title":"Exp. Parasitol."},{"issue":"47","key":"10.1016\/j.exppara.2018.04.015_bib14","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1016\/j.vaccine.2013.09.027","article-title":"Vaccine potential of recombinant saposin-like protein 2 against Fasciolosis gigantica in mice","volume":"31","author":"Kueakhai","year":"2013","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.exppara.2018.04.015_bib15","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1007\/s00436-015-4589-6","article-title":"Juvenile-specific cathepsin proteases in Fasciola spp.: their characteristics and vaccine efficacies","volume":"114","author":"Meemon","year":"2015","journal-title":"Parasitol. Res."},{"issue":"4","key":"10.1016\/j.exppara.2018.04.015_bib16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.intimp.2013.10.012","article-title":"Low dose naltrexone (LDN) enhances maturation of bone marrow dendritic cells (BMDCs)","volume":"17","author":"Meng","year":"2013","journal-title":"Int. Immunopharm."},{"issue":"12","key":"10.1016\/j.exppara.2018.04.015_bib17","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.intimp.2009.08.008","article-title":"Naloxone can improve the anti-tumor immunity by reducing the CD4+CD25+Foxp3+ regulatory T cells in BALB\/c mice","volume":"9","author":"Molla Hassan","year":"2009","journal-title":"Int. Immunopharm."},{"issue":"3","key":"10.1016\/j.exppara.2018.04.015_bib18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.biochi.2010.12.004","article-title":"Adult and juvenile Fasciola cathepsin L proteases: different enzymes for different roles","volume":"93","author":"Norbury","year":"2011","journal-title":"Biochimie"},{"issue":"12","key":"10.1016\/j.exppara.2018.04.015_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004234","article-title":"Glycans from Fasciola hepatica modulate the host immune response and TLR-induced maturation of dendritic cells","volume":"9","author":"Rodriguez","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"8","key":"10.1016\/j.exppara.2018.04.015_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105323","article-title":"In\u00a0vitro and in\u00a0vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes","volume":"9","author":"Rojas-Caraballo","year":"2014","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.exppara.2018.04.015_bib21","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.vaccine.2015.02.010","article-title":"Protection against Fasciola gigantica infection in mice by vaccination with recombinant juvenile-specific cathepsin L","volume":"33","author":"Sansri","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.exppara.2018.04.015_bib22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/08820139.2014.914531","article-title":"A\u00a0novel adjuvant, the mixture of alum and naltrexone, augments vaccine-induced immunity against Plasmodium berghei","volume":"43","author":"Shahabi","year":"2014","journal-title":"Immunol. Invest."},{"issue":"10","key":"10.1016\/j.exppara.2018.04.015_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/pim.12220","article-title":"Administration of naloxone in combination with recombinant Plasmodium vivax AMA-1 in BALB\/c mice induces mixed Th1\/Th2 immune responses","volume":"37","author":"Someabozorg","year":"2015","journal-title":"Parasite Immunol."},{"issue":"2","key":"10.1016\/j.exppara.2018.04.015_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5152\/tpd.2013.22","article-title":"A\u00a0novel adjuvant, mixture of Alum and naltrexone, elicits humoral immune responses for excreted\/secreted antigens of Toxoplasma gondii tachyzoites vaccine in Balb\/c murine model","volume":"37","author":"Tappeh","year":"2013","journal-title":"Turkiye parazitolojii dergisi"},{"issue":"2","key":"10.1016\/j.exppara.2018.04.015_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1179\/2047773215Y.0000000035","article-title":"Naloxone\/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses","volume":"110","author":"Velashjerdi Farahani","year":"2016","journal-title":"Pathog. Glob. Health"},{"issue":"10","key":"10.1016\/j.exppara.2018.04.015_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11920-014-0489-1","article-title":"Antagonist models for treating persons with substance use disorders","volume":"16","author":"Woody","year":"2014","journal-title":"Curr. Psychiatr. Rep."},{"key":"10.1016\/j.exppara.2018.04.015_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4939-3389-1_9","article-title":"Development of experimental vaccines against liver flukes","volume":"1404","author":"Yap","year":"2016","journal-title":"Meth. Mol. Biol."},{"issue":"9","key":"10.1016\/j.exppara.2018.04.015_bib28","first-page":"1003","article-title":"Potentiation of human papilloma vaccine candidate using naloxone\/alum mixture as an adjuvant: increasing immunogenicity of HPV-16E7d vaccine","volume":"19","author":"Yasaghi","year":"2016","journal-title":"Iran J. Basic Med. Sci."},{"key":"10.1016\/j.exppara.2018.04.015_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.intimp.2016.08.015","article-title":"Functional modulation on macrophage by low dose naltrexone (LDN)","volume":"39","author":"Yi","year":"2016","journal-title":"Int. Immunopharm."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489417305088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489417305088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T12:22:57Z","timestamp":1561033377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489417305088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":29,"alternative-id":["S0014489417305088"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2018.04.015","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2018.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}